Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.

Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.

“XVIVO has always responded promptly to our questions and comments. Most importantly, XVIVO created the animation that Dr. Mullis wished for — a fluid, organic visualization of his spectacularly simple process. We presented the animation during Dr. Mullis’s direct examination on the first day of trial, and it created a momentum that carried through the 4-week trial to an overwhelming victory at the end.”
Robert Cote (Partner) and Rita Berardino (Associate), Orrick, Herrington & Sutcliffe, LLP